OneMedNet Corporation ONMD · NASDAQ
$4.51 -5.05% (-$0.24)
Summary
26 / 100 · Bulios Score
What speaks for it
- It earns 363 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- Revenue growth is slowing: 5.6% a year over the last 3 years against 11% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 5.6% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $8.51M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Subscription Revenue 100%
By region
The company reports no revenue by region.
Subscription Revenue brings in 100% of revenue.
Segments in detail